Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Comparison of interventions for Barrett’s esophagus: A network meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Incidence of adenocarcinoma among patients with Barrett’s esophagus
10.1056/nejmoa1103042 · 2011 · External reference
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021
10.1007/s00535-022-01861-z · 2022 · External reference
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review
10.1016/j.cgh.2022.06.003 · 2022 · External reference
Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2022.
10.1055/a-1811-7025 · 2022 · External reference
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.
2010 · External reference
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses—an overview and application of NetMetaXL.
2014 · External reference
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
2015 · External reference
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
2011 · External reference
Evaluating the quality of evidence from a network meta-analysis.
2014 · External reference
Graphical tools for network meta-analysis in STATA.
2013 · External reference
Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial
10.1136/gut.47.5.612 · 2000 · External reference
Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation
10.1111/j.1572-0241.2000.02300.x · 2000 · External reference
Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression.
10.1055/s-2002-35847 · 2002 · External reference
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus
10.1097/01.sla.0000055269.77838.8e · 2003 · External reference
Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s esophagus after antireflux surgery
10.1016/s0016-5107(03)02528-8 · 2004 · External reference
5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial
10.1136/gut.2003.028860 · 2004 · External reference
Endoscopic ablation of Barrett’s oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation
10.1111/j.1365-2036.2004.02277.x · 2004 · External reference
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial.
10.1016/j.gie.2005.06.047 · 2005 · External reference
Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness
10.1080/00365520510015737 · 2005 · External reference
A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results
10.1136/gut.2005.086777 · 2006 · External reference
Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results
10.1097/sla.0b013e318133fa85 · 2007 · External reference
Secondary chemoprevention of Barrett’s esophagus with celecoxib: results of a randomized trial
10.1093/jnci/djk112 · 2007 · External reference
Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus in patients treated with antisecretory medication
10.1007/s10620-008-0662-7 · 2009 · External reference
Radiofrequency ablation in Barrett’s esophagus with dysplasia
10.1056/nejmoa0808145 · 2009 · External reference
Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial
10.1136/gut.2010.229310 · 2011 · External reference
Argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus: late outcomes from two randomized trials.
10.1055/s-0033-1344584 · 2013 · External reference
Ablation of residual Barrett’s epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
2014 · External reference
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial
10.1001/jama.2014.2511 · 2014 · External reference
Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia
10.1080/00365521.2017.1403646 · 2018 · External reference
Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett’s esophagus: a randomized pilot study (BRIDE).
10.1016/j.gie.2018.07.031 · 2019 · External reference
Endoscopic radiofrequency ablation or surveillance in patients with Barrett’s oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial
10.1136/gutjnl-2020-322082 · 2021 · External reference
Argon plasma coagulation for Barrett’s esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose.
10.1055/a-1203-5930 · 2021 · External reference
Endoscopic ablation of Barrett’s esophagus using the second generation argon plasma coagulation: a prospective randomized controlled trail
10.1016/s1007-4376(09)60052-6 · 2009 · External reference
The tissue effect of argon-plasma coagulation with prior submucosal injection (Hybrid-APC) versus standard APC: A randomized ex-vivo study.
10.1177/2050640614544315 · 2014 · External reference
Hybrid APC in Combination With Resection for the Endoscopic Treatment of Neoplastic Barrett’s Esophagus: A Prospective, Multicenter Study
10.14309/ajg.0000000000001539 · 2022 · External reference
Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett’s esophagus: US pilot study
10.1055/a-1492-2450 · 2021 · External reference
Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.
10.1067/mge.2001.114418 · 2001 · External reference
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
10.1038/ajg.2015.322 · 2016 · External reference
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
10.1055/s-0042-122140 · 2017 · External reference
Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients.
10.1016/s0016-5107(99)70437-2 · 1999 · External reference
Progression of Barretl’s esophagus to high grade dysplasia and cancer: Preliminary results of the BEST (Barrett’s esophagus study) trial.
10.1016/s0016-5085(01)80081-0 · 2001 · External reference
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagus
1997 · External reference
Partial regression of Barrett’s esophagus by long-term therapy with high-dose omeprazole.
10.1016/s0016-5107(96)70055-x · 1996 · External reference
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
10.1055/a-2176-2440 · 2023 · External reference
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia.
10.1016/j.gie.2006.12.037 · 2007 · External reference
Photodynamic therapy for Barrett’s esophagus: clinical update
1996 · External reference
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid
10.1016/s0016-5085(98)70527-x · 1998 · External reference
Photodynamic therapy of Barrett’s esophagus.
10.1016/s1052-5157(18)30113-2 · 2000 · External reference
Cost-effectiveness of photodynamic therapy for treatment of Barrett’s esophagus with high grade dysplasia
10.1023/a:1024146823549 · 2003 · External reference
What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis
10.1136/gut.2003.033837 · 2004 · External reference
Photodynamic therapy for Barrett’s esophagus with high-grade dysplasia: a cost-effectiveness analysis
10.1155/2007/791062 · 2007 · External reference
Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials.
10.3389/fonc.2022.801940 · 2022 · External reference
Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma.
10.1016/j.gtc.2015.02.001 · 2015 · External reference
Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis
10.1097/sla.0000000000001438 · 2016 · External reference
